WO2010066846A3 - Method for the isolation of atorvastatin - Google Patents

Method for the isolation of atorvastatin Download PDF

Info

Publication number
WO2010066846A3
WO2010066846A3 PCT/EP2009/066852 EP2009066852W WO2010066846A3 WO 2010066846 A3 WO2010066846 A3 WO 2010066846A3 EP 2009066852 W EP2009066852 W EP 2009066852W WO 2010066846 A3 WO2010066846 A3 WO 2010066846A3
Authority
WO
WIPO (PCT)
Prior art keywords
atorvastatin
butanol
branched
alcohol
linear
Prior art date
Application number
PCT/EP2009/066852
Other languages
French (fr)
Other versions
WO2010066846A2 (en
Inventor
De Ben Lange
Henricus Leonardus Marie Elsenberg
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2010066846A2 publication Critical patent/WO2010066846A2/en
Publication of WO2010066846A3 publication Critical patent/WO2010066846A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a method for isolating atorvastatin comprising mixing at a temperature not exceeding 50°C a solution of atorvastatin in methanol and/or ethanol and/or n-propanol with isopropanol and/or n-butanol and/or sec-butanol and/or tert-butanol and/or a linear or branched C5-alcohol and/or a linear or branched C6-alcohol and/or a linear or branched C7-alcohol, followed by isolating the precipitate thus obtained, optionally in the presence of one or more antioxidants.
PCT/EP2009/066852 2008-12-11 2009-12-10 Method for the isolation of atorvastatin WO2010066846A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08171331 2008-12-11
EP08171331.5 2008-12-11

Publications (2)

Publication Number Publication Date
WO2010066846A2 WO2010066846A2 (en) 2010-06-17
WO2010066846A3 true WO2010066846A3 (en) 2011-03-17

Family

ID=40436318

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/066852 WO2010066846A2 (en) 2008-12-11 2009-12-10 Method for the isolation of atorvastatin

Country Status (1)

Country Link
WO (1) WO2010066846A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042209A1 (en) * 1999-12-10 2001-06-14 Lek Pharmaceutical And Chemical Company D.D. Process for the preparation of amorphous atorvastatin
US6274740B1 (en) * 1995-07-17 2001-08-14 Warner-Lambert Company Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethy)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
WO2006046109A1 (en) * 2004-10-28 2006-05-04 Warner-Lambert Company Llc Process for forming amorphous atorvastatin
US7230120B2 (en) * 2002-03-18 2007-06-12 Biocon Amorphous HMG-CoA reductase inhibitors of desired particle size
WO2008096377A2 (en) * 2007-02-09 2008-08-14 Actavis Group Ptc Ehf Stable atorvastatin formulations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274740B1 (en) * 1995-07-17 2001-08-14 Warner-Lambert Company Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethy)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
WO2001042209A1 (en) * 1999-12-10 2001-06-14 Lek Pharmaceutical And Chemical Company D.D. Process for the preparation of amorphous atorvastatin
US7230120B2 (en) * 2002-03-18 2007-06-12 Biocon Amorphous HMG-CoA reductase inhibitors of desired particle size
WO2006046109A1 (en) * 2004-10-28 2006-05-04 Warner-Lambert Company Llc Process for forming amorphous atorvastatin
WO2008096377A2 (en) * 2007-02-09 2008-08-14 Actavis Group Ptc Ehf Stable atorvastatin formulations

Also Published As

Publication number Publication date
WO2010066846A2 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
WO2011044279A3 (en) Microbial systems for producing commodity chemicals
EP2374530A4 (en) Foaming composition for high temperature and salinity
WO2012061290A3 (en) Pesticidal compositions and processes related thereto
EP2262058A4 (en) Board-shaped wideband dual polarization antenna
WO2009155001A3 (en) Wnt protein signalling inhibitors
WO2011063363A3 (en) Production of an organic acid and/or related chemicals
WO2010014632A3 (en) Methods and compositions for improving the production of products in microorganisms
GEP20146057B (en) Alcoholic compositions having lowered risk of acetaldehydemia
WO2010014631A3 (en) Methods and compositions for improving the production of products in microorganisms
EP2468400A4 (en) Catalyst and alcohol synthesis method
EP2460224A4 (en) Antenna system and connector for antenna
WO2008094621A3 (en) Methods for allergen detection
BRPI0921483A2 (en) improved ethanol fermentation using biodigested
WO2010011834A3 (en) Process for the preparation of sunitinib malate via sunitinib acetate and their polymorphs
WO2011057006A3 (en) Insecticidal fermentation broth from actinomycetes
WO2009148918A3 (en) Inertially-assisted electric supercharger
WO2010066846A3 (en) Method for the isolation of atorvastatin
WO2011056930A9 (en) Fragile x mental retardation protein (fmrp), compositions, and methods related thereto
WO2010001167A3 (en) Preparation of 3-pyrrole substituted 2-indolinone derivatives
WO2010006153A3 (en) Topopyrones: dual topoisomerase inhibitors
WO2008070412A3 (en) Methods and compositions for reanimating cryopreserved oocytes
WO2008075072A3 (en) Formulation
WO2007133571A3 (en) Methods and compositions related to tr4
EP2369675A4 (en) Internal antenna supporting wideband impedance matching
WO2011069149A3 (en) Cathepsin s inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09765130

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09765130

Country of ref document: EP

Kind code of ref document: A2